Mirum Pharmaceuticals (MIRM) Shares Outstanding (2018 - 2026)

Mirum Pharmaceuticals' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $60.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 23.2% year-over-year to $60.9 million; the TTM figure through Mar 2026 stood at $60.9 million (up 23.2% YoY), while the FY2025 annual figure was $51.9 million, up 7.36% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $60.9 million, up from $51.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $60.9 million in Q1 2026, with the low at $31.7 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $47.1 million (2024), against an average of $44.8 million.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) advanced 26.57% in 2023, then advanced 2.95% in 2024.
• Mirum Pharmaceuticals' Shares Outstanding (Entity) stood at $37.0 million in 2022, then gained by 26.43% to $46.7 million in 2023, then increased by 3.46% to $48.3 million in 2024, then climbed by 7.36% to $51.9 million in 2025, then gained by 17.4% to $60.9 million in 2026.
• Business Quant data shows MIRM's Shares Outstanding (Entity) at $60.9 million in Q1 2026, $51.9 million in Q4 2025, and $51.3 million in Q3 2025.